Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. Corrected, July 23, 2024: An earlier version of this ...
The heat on healthcare’s middlemen — pharmacy benefit managers (PBM) — is increasing, but a tangible solution may still be far off. Lawmakers grilled PBM executives Tuesday at the third hearing in a ...
In a conversation hosted by DSN, EmpiRx Health CEO Danny Sanchez and EmpiRx Health President John Ridyard detailed how their mid-market PBM is gaining traction by putting pharmacists at the center of ...
The House Committee on Oversight and Government Reform said last week that it’s expanding its investigation into the role of pharmacy benefit managers by seeking information about how they use foreign ...
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results